|
Characteristic
|
Model 1
|
Model 2
|
|---|
| |
HR (95 % CI)
|
P value
|
HR (95 % CI)
|
P value
|
|---|
|
N stage (N2-3 vs. N0-1)
|
1.42(1.18, 1.72)
|
<0.001
|
1.39(1.15,1.68)
|
0.001
|
|
Number of metastatic lesions (≥2 vs. 1)
|
1.73(1.29, 2.32)
|
<0.001
|
1.87(1.40,2.52)
|
<0.001
|
|
Liver metastasis (present vs. absent)
|
1.38(1.14, 1.67)
|
0.001
|
1.29(1.06,1.57)
|
0.010
|
|
Lymphocyte count (≥1.390 × 109/L vs. <1.390 × 109/L)
|
NA
|
NA
|
0.77(0.64,0.93)
|
0.007
|
|
Monocyte count (≥0.665 × 109/L vs. <0.665 × 109/L)
|
NA
|
NA
|
1.98(1.63,2.41)
|
<0.001
|
|
LMR (≥2.475 vs. <2.475)
|
0.50(0.41, 0.60)
|
<0.001
|
NA
|
NA
|
- NA, not applicable. Other footnotes as in Table 1
